Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer’s disease in individuals with subjective cognitive decline Alzheimer’s Research and Therapy (2023) 15 (1), 2 DOI: 10.1186/s13195-022-01143-z Pascual-Lucas, Allué, Sarasa et al (2024)
Alzheimer’s Research and Therapy (2023) 15 (1), 2 DOI: 10.1186/s13195-022-01143-z
